Global marketing and registration of finished dosage forms

Breathing life into markets

We are your perfect partner for an early and global market entry!

We at Tiefenbacher strongly believe that our high-quality medicines should be available and affordable for all patients – irrespective of their origin or income level. That´s why we always strive for a global and early market entry for our customers. Thanks to our high excellence and international knowledge in research & development and regulatory affairs, we have already obtained more than 15.000 marketing authorizations in over 80 markets worldwide.

While we master the complexity of country-specific regulatory requirements and maintain close contact to the relevant pharmaceutical authorities, our customers can focus on their important brand marketing and save time and money. Outstanding intellectual property guidance, a professional project management, and an efficient supply chain approach are further important drivers for our strong track record in generating first-to-file-dossiers.

Our global licensing approach

Global availability of our high-quality developments: marketing authorizations in 80+ countries

15.000+

marketing authorizations worldwide

15.000+

marketing authorizations worldwide

Tiefenbacher market access at a glance

Our strong track record in marketing and registration speaks for us

15.000+

MAs obtained

in80+

countries worldwide

150+

marketing partners on five continents

350+

tender awards in 12 months

15.000+

MAs obtained

in80+

countries worldwide

150+

marketing partners on five continents

350+

tender awards in 12 months

highly rated regulatory expertise

frequent first-to-file generic dossiers

first NCE approved

several US filings

highly rated regulatory expertise

frequent first-to-file generic dossiers

first NCE approved

several US filings

Dr. Kristian Ruepp

Managing Director

„Thanks to our international knowledge in R&D and regulatory affairs, we enable our customers to enter global markets as fast as possible – making our high-quality medicines more affordable and more available for patients worldwide."

We are happy to help, get in touch

Thanks to our extensive experience and profound expertise in the international pharmaceutical markets, we can help you achieve sustainable and profitable growth with our advanced medicines. Contact us.



    Find out more on aet.eu